Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Moodys
Colorcon
Baxter
Express Scripts

Last Updated: December 9, 2021

DrugPatentWatch Database Preview

IMAGENT Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Imagent, and what generic alternatives are available?

Imagent is a drug marketed by Vesselon Spv Llc and Alliance Pharm and is included in two NDAs.

The generic ingredient in IMAGENT is perflubron. Additional details are available on the perflubron profile page.

US Patents and Regulatory Information for IMAGENT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Alliance Pharm IMAGENT perflubron LIQUID;ORAL 020091-001 Aug 13, 1993 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for IMAGENT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Try it Free ⤷  Try it Free
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Try it Free ⤷  Try it Free
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Try it Free ⤷  Try it Free
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Try it Free ⤷  Try it Free
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Try it Free ⤷  Try it Free
Vesselon Spv Llc IMAGENT dimyristoyl lecithin; perflexane INJECTABLE;INTRAVENOUS 021191-001 May 31, 2002 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Johnson and Johnson
Medtronic
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.